Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-23
1988-01-26
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546197, A61K 31445, C07D40512
Patent
active
047217235
ABSTRACT:
The invention provides crystalline paroxetine hydrochloride hemihydrate, processes for its preparation, compositions containing the same and its therapeutic use as an anti-depressant.
REFERENCES:
patent: 4007196 (1977-02-01), Christensen
Chemical Abstracts, 95:54664z (1981) [Goethert, M., et al., Naunyn-Schmiedeberg's Arch. Pharmacol. 1980, 313(1), 21-6].
J. B. Lassen, Psychopharmacology, 57, pp. 151-153 (1978).
J. B. Lassen, European J. Pharmacol., 47, pp. 351-358 (1978).
J. Lund et al., Acta Pharmacol. et Toxicol., 44, pp. 289-295 (1979).
J. B. Lassen, et al., Psychopharmacology, 68, pp. 229-233 (1980).
Barnes Roger D.
Buxton Philip C.
Curzons Alan D.
Lynch Ian R.
Richardson John E.
Beecham Group p.l.c.
Gordon Alan M.
Haley, Jr. James F.
Schwartz Richard A.
LandOfFree
Anti-depressant crystalline paroxetine hydrochloride hemihydrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-depressant crystalline paroxetine hydrochloride hemihydrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-depressant crystalline paroxetine hydrochloride hemihydrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1468229